IP Library Granted Patent US 7,232,909
Granted Patent B2
US 7,232,909 · App. 11/240,728 · Granted Jun 19, 2007

Pyridine derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,232,909
App. No.
11/240,728
Granted
Jun 19, 2007
Kind
B2
Abstract

This invention is to provide a process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs and salts thereof, comprising the reaction shown by the following scheme. The ester analogs can be prepared in one pot, and in good yield by using tertiary alkyl cyanoacetate. Furthermore, the method is useful for preparing derivatives of various analogs of the ester, e.g. alkyl substituted and aryl substituted analogs.

Claims (77)

1. A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs and salts thereof, comprising reacting the compounds of formulae (I), (II), (III), and an ammonium salt in accordance with the following scheme:

wherein

Ar is an aryl or heteroaryl group, and optionally substituted by one or more substituents;

R 1 is hydrogen, halogen, or C 1-6 alkyl;

R 2 is optionally substituted aryl, heteroaryl, alkyl or alkenyl; and

R 3 is —CR 21 R 22 R 23 ,

wherein

R 21 , R 22 and R 23 are each independently C 1-6 alkyl or aryl.

2. The process as claimed in claim 1 , wherein:

Ar is phenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-thienyl, 3-thienyl, 2-furyl, 3-furyl, 1-naphthyl, 2-naphthyl, 2-quinolyl, 3-quinolyl, 4-quinolyl, 5-quinolyl, 6-quinolyl, 7-quinolyl or 8-quinolyl and optionally substituted by one or more substituents,

wherein the optional substituents are each independently hydrogen, C 1-6 alkyl, halogen, C 1-12 alkoxy, cyano, nitro, C 1-6 alkylsulfonylamino, C 1-6 alkoxycarbonyl, di C 1-6 alkylamino, C 1-6 alkylcarbonylamino, —S—(CH 2 ) n —R 11 or —O—(CH 2 ) n —R 11 ,

wherein

n represents an integer selected from 0 to 6, and

R 11 is C 2-6 alkenyl, benzoyl, diphenylmethyl, di(C 1-6 alkyl)amino, C 1-6 alkanoyl, C 1-6 alkoxycarbonyl, or an optionally substituted 3 to 10 membered saturated or unsaturated ring having 0 to 3 heteroatoms selected from the group consisting of S, O and N as heteroatoms;

R 1 is hydrogen, halogen, or C 1-6 alkyl;

R 2 is optionally substituted phenyl or styryl;

wherein the optional substituents are each independently hydrogen, halogen, C 1-6 alkoxy, di C 1-6 alkylamino, C 1-6 alkanoylamino, C 1-6 alkyl(hydroxy C 1-6 alkyl)amino, C 1-6 alkyl(benzyl)amino, morpholino, C 1-6 alkylsulfonylamino, optionally substituted piperidino, optionally substituted pyrrolidino, piperidino-C 1-6 alkylene-oxy, —CO—NHR 51 , or NH—COR 51 ,

wherein

R 51 represents piperidino-C 1-6 alkylene, carboxy-C 1-6 alkylene, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkylene, oxotetrahydrofuryl, oxopyrrolidinyl, —CH(OH)R 51a , or —C 1-6 alkylene-R 51b ,

wherein

R 51 is carboxy-C 1-6 alkylene or C 1-6 alkoxycarbonyl-C 1-6 alkylene,

R 51b is optionally substituted piperidino, optionally substituted piperazino, optionally substituted amino, or —CH(NH 2 )— carboxy,

N-protected amino-C 1-6 alkylene, or 5 to 8 membered saturated ring having 0 to 3 N as heteroatoms and the N atom is protected;

—CR 31 R 32 R 33 ,

wherein R 31 is hydrogen or C 1-6 alkyl,

R 32 is hydrogen, a 5 to 8 membered saturated ring having 0 to 3 atoms selected from the group consisting of S, O and N as heteroatoms, or optionally substituted C 1-6 alkyl, and

R 33 is hydrogen, amino, C 1-6 alkoxycarbonylamino, C 2-6 alkenyl-oxycarbonylamino, benzyloxycarbonylamino or

R 32 and R 33 may form, together with the adjacent carbon atom, an optionally substituted or optionally benzene fused 5 to 8 membered saturated ring having 0 to 3 heteroatoms selected from the group consisting of N, O and S as heteroatoms; and

R 3 is a —CR 21 R 22 R 23 ,

wherein

R 21 , R 22 and R 23 are each independently C 1-6 alkyl or phenyl.

3. The process as claimed in claim 1 , wherein:

Ar is phenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, 2-thienyl, 3-thienyl, 2-furyl, 3-furyl, 1-naphthyl, 2-naphthyl, 2-quinolyl, 3-quinolyl, 4-quinolyl, 5-quinolyl, 6-quinolyl, 7-quinolyl or 8-quinolyl and optionally substituted by one or more substituents,

wherein the optional substituents are each independently hydrogen, C 1-6 alkyl, halogen, C 1-12 alkoxy, cyano, nitro, C 1-6 alkylsulfonylamino, C 1-6 alkoxycarbonyl, di C 1-6 alkylamino, C 1-6 alkylcarbonylamino, —S—(CH 2 ) n —R 11 , or —O—(CH 2 ) n —R 11 ,

wherein

n represents an integer selected from 0 to 6, and

R 11 is C 2-6 alkenyl, benzoyl, diphenylmethyl, di (C 1-6 alkyl)amino, C 1-6 alkanoyl, C 1-6 alkoxycarbonyl, optionally substituted 3 to 10 membered saturated or unsaturated ring having 0 to 3 heteroatoms selected from the group consisting of S, O and N as heteroatoms, which ring is optionally substituted by one or more substituents selected from the group consisting of C 1-6 alkyl, C 1-6 alkoxy, halogen, C 1-6 alkoxycarbonyl, C 1-6 alkylsulfonyl, halogen substituted alkyl, nitro, cyano, hydroxy, phenyl, amino, C 1-6 alkylamino, C 3-8 cycloalkylamino, benzylamino, carbamoyl, —O— 1-6 alkylene-phenyl, and —O-phenyl;

R 1 is hydrogen, halogen, or C 1-6 alkyl;

R 2 is optionally substituted phenyl or styryl;

wherein the optional substituents are each independently hydrogen, halogen, amino, C 1-6 alkoxy, di C 1-6 alkylamino, C 1-6 alkanoylamino, C 1-6 alkyl(hydroxy C 1-6 alkyl)amino, C 1-6 alkyl(benzyl)amino, morpholino, C 1-6 alkylsulfonylamino, optionally substituted piperidino, optionally substituted pyrrolidino, piperidino-C 1-6 alkylene-oxy, —CO—NHR 51 , or —NH—COR 51 ,

wherein

R 51 represents piperidino-C 1-6 alkylene, carboxy-C 1-6 alkylene, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkylene, oxotetrahydrofuryl, oxopyrrolidinyl, —CH(OH)R 51a , or —C 1-6 alkylene-R 51b ,

wherein

R 51a is carboxy-C 1-6 alkylene or C 1-6 alkoxycarbonyl-C 1-6 alkylene,

R 51b is —NHR 51b-1 (wherein R 51b-1 represents hydrogen, C 1-6 alkyl, —C 1-6 alkylene-O—C 1-6 alkyl, hydroxy-C 1-6 alkylene, or piperidino-C 1-6 alkylene), —CH(NH 2 )—COOH, pyrroline, or —N(C 1-6 alkyl)R 51b-2 (wherein R 51b-2 represents C 1-6 alkyl or ethylpyrrolidine),

piperidino optionally substituted by carboxy or C 1-6 alkoxycarbonyl, piperazino fused with cyclohexane,

piperazino optionally substituted by C 1-6 alkyl, benzyl, hydroxy-C 1-6 alkylene, C 1-6 alklyl-carbonyl, cyclohexane, benzodioxane-C 1-6 alkylene, or furyl-carbonyl,

N-protected amino-C 1-6 alkylene, N-protected 2-piperidyl, N-protected 3-piperidyl or N-protected 4-piperidyl;

—CR 31 R 32 R 33 ,

wherein

R 31 is hydrogen or C 1-6 alkyl,

R 32 is hydrogen; C 1-6 alkyl optionally substituted by hydroxy, amino, phenyl, C 1-6 alkoxyphenyl, halophenyl or aminophenyl; or a 5 to 8 membered saturated ring having 0 to 3 atoms selected from the group consisting of S, O and N as heteroatoms, and

R 33 is hydrogen, amino, C 1-6 alkoxycarbonylamino, C 2-6 alkenyloxy-carbonylamino, or benzyloxycarbonylamino or

R 32 and R 33 may form, together with the adjacent carbon atom, an optionally substituted 5 to 8 membered saturated ring having 0 to 3 heteroatoms selected from the group consisting of N, O and S as heteroatoms, which ring is optionally be substituted by one or more substituents selected from the group consisting of C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxycarbonyl, C 1-6 alkylsulfonyl, halogen substituted alkyl, nitro, cyano, hydroxy, phenyl, amino, C 1-6 alkylamino, C 3-8 cycloalkylamino, benzylamino, carbamoyl, —O—C 1-6 alkylene-phenyl, —O-phenyl, phenyl-C 1-6 alkyl, di C 1-6 alkylamino, and piperidino-C 1-6 alkylcarbonyl, or said ring may be fused with a benzene ring; and

R 3 is t-butyl, 1,1-dimetlylpropyl or trityl group.

4. The process as claimed in claim 1 , wherein:

Ar is phenyl, and optionally substituted by one substituent,

wherein the optional substituent is hydrogen, C 1-2 alkoxy, or —O—C 1-6 alkylene-R 11 ,

wherein

R 11 is vinyl, diphenylmethyl, C 1-6 alkanoyl, optionally substituted C 5-10 aryl, or optionally substituted 5 to 10 membered heteroaryl, optionally substituted 3 to 8 membered cycloalkyl optionally interrupted by O atom, or a 5 to 8 membered saturated heterocyclic ring interrupted by NH and/or O;

R 1 is hydrogen;

R 2 is optionally substituted phenyl or styryl;

wherein the optional substituents are each independently hydrogen, halogen, amino, C 1-6 alkoxy, di C 1-6 alkylamino, C 1-6 alkanoylamino, C 1-6 alkyl(hydroxy C 1-6 alkyl)amino, C 1-6 alkyl(benzyl)amino, morpholino, C 1-6 alkylsulfonylamino, optionally substituted piperidino, optionally substituted pyrrolidino, piperidino-C 1-6 alkylene-oxy, —CO—NHR 51 , or —NH—COR 51 ,

wherein

R 51 represents piperidino-C 1-6 alkylene, carboxy-C 1-6 alkylene, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 alkoxy-C 1-6 alkylene, oxotetrahydrofuryl, oxopyrrolidinyl, —CH(OH)R 51a , or —C 1-6 alkylene-R 51b ,

wherein

R 51a is carboxy-C 1-6 alkylene or C 1-6 alkoxycarbonyl-C 1-6 alkylene,

R 51b is —NHR 51b-1 (wherein R 51b-1 represents hydrogen, C 1-6 alkyl, —C 1-6 alkylene-O—C 1-6 alkyl, hydroxy-C 1-6 alkylene, piperidino-C 1-6 alkylene), —CH(NH 2 )—COOH, pyrroline, —N(C 1-6 alkyl)R 51b-2 (wherein R 51b-2 represents C 1-6 alkyl or ethylpyrrolidine),

piperidino optionally substituted by carboxy or C 1-6 alkoxycarbonyl, piperazino fused with cyclohexane, or piperazino optionally substituted by C 1-6 alkyl, benzyl, hydroxy-C 1-6 alkylene, C 1-6 alkyl-carbonyl, cyclohexane, benzodioxane-C 1-6 alkylene, or furyl-carbonyl,

N-protected amino-C 1-6 alkylene, N-protected 2-piperidyl, N-protected 3-piperidyl or N-protected 4-piperidyl;

—CR 31 R 32 R 33 ,

wherein

R 31 is hydrogen or C 1-6 alkyl,

R 32 is hydrogen, or C 1-6 alkyl optionally substituted by hydroxy, amino, phenyl, C 1-6 alkoxyphenyl, halophenyl, or aminophenyl, and

R 33 is hydrogen, amino, or benzyloxycarbonylamino; or R 32 and R 33 may form optionally substituted C 5-8 cycloalkyl optionally interrupted by NH, wherein said substituent is C 1-6 alkyl, phenyl-C 1-6 alkyl, amino, C 1-6 alkylamino, benzylamino, di C 1-6 alkylamino, carbamoyl, C 1-6 alkoxy-carbonyl, piperidino-C 1-6 alkylcarbonyl, or C 1-6 alkylsulfonyl, and said ring may be fused with a benzene ring;

R 3 is t-butyl group.

5. The process as claimed in claim 1 , wherein the ammonium salt is ammonium acetate.

Assignments (1)
MERGER Recorded Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →